Probe into Gambia deaths linked to India-made cough syrup
WHO says the UN agency is investigating deaths from acute kidney injuries with India's drug regulator and New Delhi-based cough syrup manufacturer.
Just In
India is investigating the deaths of dozens of children in Gambia that the World Health Organization (WHO) said may be linked to a cough syrup made in the south Asian nation, two people from India's health ministry told Reuters on Thursday.
WHO director-general Tedros Adhanom Ghebreyesus on Wednesday told reporters the UN agency was investigating the deaths from acute kidney injuries with India's drug regulator and New Delhi-based cough syrup manufacturer Maiden Pharmaceuticals.
The agency informed the Drugs Controller General of India of the deaths late last month after which the regulator launched an investigation with state authorities, in tandem with the WHO probe, the people said.
Maiden manufactured and exported the syrup only to the West African nation, the people said.
Reuters' calls to a listed telephone number for Maiden went unanswered as did an emailed request for comment. Calls to the Drugs Controller General of India outside of office hours also went unanswered.
India's government has asked WHO to share its report linking the deaths with the cough syrup and will take "all required steps in the matter", the people said.
Subscribe to our newsletter
To be updated with all the latest news and analyses daily.
